Study S000462

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02527993
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 11
Start: 2015-10
Primary completion: 2017-04-08
Lead sponsor: Zealand University Hospital
Conditions: Hypoglycemia; Obesity; Surgery
Interventions: DRUG:Glucobay (acarbose); DRUG:Januvia (sitagliptin); DRUG:Verapamil HEXAL (verapamil); DRUG:Victoza (liraglutide); DRUG:Signifor (pasireotide); DEVICE:Continuous glucose monitoring (CGM); DIETARY_SUPPLEMENT:Meal tolerance test (MTT)
Results posted: FALSE

Registered primary outcomes

Changes in blood glucose (mmol/L) assessed by continuous glucose monitoring (CGM). [6 days CGM will be performed at week 1, 3, 5, 7 and 11.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0027619	Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass. Øhrstrøm CC, Obesity surgery	2020	Other trial	PMID 31907828 DOI	cites ClinicalTrials.gov:NCT02527993; registry reference DERIVED:31907828